BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Foster Corporation Offers Non-Migratory Antistatic Polymers for Medical Applications


10/29/2013 9:10:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PUTNAM, CT USA - (October 29, 2013) - Foster Corporation, a leader in custom polymers for medical devices, introduces static dissipative polymer blends specifically designed for medical devices and equipment. These blends use a non-migratory, polyether block amide (PEBA) polymer additive that retains continuous antistatic properties and cannot be wiped off with medical cleaning agents.

Dissipation of static electricity is critical to avoid damage to electronic circuitry and reduce particle build-up on medical devices and surrounding surfaces. New devices, such as vascular imaging catheters, utilize highly sensitive electronics for enhanced diagnosis and treatment. Dissipation of static electricity that can build up on surrounding surfaces is critical to avoid damage to sensitive electronic circuitry in these devices. In drug delivery devices, such as dry powder inhalers, static charge can cause accumulation of drug particles on the device surface and lead to variability in dose delivery. As a leading provider of specialty compounds for medical devices, Foster recognizes the need for static dissipation in emerging devices and offers these USP Class VI complaint blends for use in regulated applications.

The PEBA polymer additive used in Foster’s static dissipative blends, disperses throughout the entire base polymer. When melt blended in quantities between 10 and 20% by weight into other polymers it provides immediate and permanent antistatic properties of 1010-12 ohm/sq, depending on the loading and the base polymer. These antistatic properties are maintained in the polymer blend even at low humidity levels.

This unique polymer additive can be compounded into other polymers with compatible melting temperatures, including thermoplastic polyurethanes (TPU), polyethylene (PE), polypropylene (PP), polymethyl-methacrylate (PMMA), acrylonitrile butadiene styrene (ABS) and polyvinyl chloride (PVC).

“Traditional antistatic additives, such as ethoxylated amines, migrate to the component surface where they attract atmospheric moisture that helps dissipate static charges. These materials require time to migrate and a minimum level of moisture in the air. They can also easily be wiped off the surface with cleaning agents,’ said Bill Blasius, Manager of R&D and Polymer Science for Foster Corporation. “The PEBA additive provides a continuous polymer network throughout the host polymer that is intrinsically antistatic and permanent.”

For more information about antistatic polymer blends, please visit www.fostercomp.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES